Healthcare Services

Osteoarthritis Market Expected To Witness Revenue Growth Toward $11.91 Billion By 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Osteoarthritis Market By 2030 Based On Its 2026 Value?

The osteoarthritis market has experienced robust growth in recent years. It is projected to expand from $7.49 billion in 2025 to $8.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. This historical growth can be attributed to the rising global prevalence of osteoarthritis, the limited availability of advanced joint therapies in earlier periods, an increasing aging population affected by joint degeneration, the early adoption of conventional medications and surgeries, and a growing awareness of joint health and pain management.

The market for osteoarthritis is projected to experience robust expansion over the coming years. This market is anticipated to reach $11.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This projected growth is driven by several factors including the increasing acceptance of minimally invasive and robotic-assisted surgical procedures, the greater application of biologics and disease-modifying osteoarthritis drugs (DMOADs), an expanding healthcare framework dedicated to joint care, the growing embrace of digital diagnostics and AI-powered monitoring solutions, and enhanced patient understanding regarding lifestyle and weight management initiatives. Key trends anticipated during this period involve the rising uptake of minimally invasive joint replacement surgeries, an increase in the utilization of biologic therapies and hyaluronic acid injections, the growing incorporation of digital imaging and AI-based diagnostic tools, an elevated emphasis on individualized osteoarthritis management strategies, and increased financial commitment to physical therapy and rehabilitation programs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What Core Drivers Are Transforming The Osteoarthritis Market?

The growing incidence of obesity-related health issues is anticipated to propel the expansion of the osteoarthritis market moving forward. These problems refer to a spectrum of health conditions that can stem from an excess of body fat. Obesity often arises from consuming more calories than the body expends through physical activity and exercise, coupled with consuming large quantities of processed or fast food, and excessive alcohol consumption. Obesity can induce osteoarthritis by placing strain on joints, causing inflammation, and altering hormone levels, thereby increasing the load on the joints. For instance, in September 2024, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, the count of states with an adult obesity prevalence of 35% or higher increased from 22 states in 2022 to 23 states in 2023. Consequently, the rising prevalence of obesity-related disorders is a key driver for the growth of the osteoarthritis market.

How Are Different Segment Groups Identified Within The Osteoarthritis Market?

The osteoarthritis market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Therapy

2) By Diagnosis: Imaging, Joint Fluid Analysis

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

5) By End-User: Hospitals, Medical Institutes

Subsegments:

1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

Which Trends Are Affecting The Osteoarthritis Market Framework?

Within the orthopedic soft tissue repair market, prominent companies are actively engaged in developing technological advancements such as dynamic soft tissue stabilization systems. These innovations are focused on enhancing surgical precision, promoting physiological ligament motion, and mitigating complications typically associated with rigid fixation. Unlike conventional rigid screw-based fixation devices, which can restrict movement and often require removal, a dynamic soft tissue stabilization system utilizes a flexible construction that facilitates controlled micromotion while securing ligaments. This approach closely mimics natural biomechanics and supports biological healing. For example, in September 2024, Paragon 28, Inc., a U.S.-based medical device company, introduced the R3FLEX Stabilization System, which is engineered for the anatomical repair of ankle syndesmotic (soft-tissue) injuries occurring after fractures or high ankle sprains. The R3FLEX Stabilization System integrates a titanium fibular component with a tibial all-suture anchor, connected by a short suture loop and a thermoplastic polyurethane (TPU) bumper, which enables controlled micromotion while providing initial stability. The system also incorporates a turn-handle mechanism for intraoperative tension adjustment and visualization, catering to a broad spectrum of patient anatomies.

Which Organizations Are Operating Within The Osteoarthritis Market?

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Access The Complete Osteoarthritis Market Report:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Which Region Leads The Osteoarthritis Market By Size?

North America was the largest region in the osteoarthritis market in 2025. The regions covered in the osteoarthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Osteoarthritis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

Browse Through More Reports Similar to the Global Osteoarthritis Market 2026, By The Business Research Company

Soft Tissue Repair Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/soft-tissue-repair-global-market-report

Orthopedic Regenerative Surgical Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthopedic-regenerative-surgical-products-global-market-report

Cartilage Repair Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cartilage-repair-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795